Secondary Logo

Journal Logo

ERRATUM

A genome-wide association study identifies four genetic markers for hematological toxicities in cancer patients receiving gemcitabine therapy: Erratum

Pharmacogenetics and Genomics: October 2014 - Volume 24 - Issue 10 - p 530
doi: 10.1097/FPC.0000000000000078
  • Free

The authors notify readers of the following errors in Table 2 of this article 1. These errors do not affect the conclusions of the article.

Table 2
Table 2:
Summary of association results of GWAS and replication study

Table 2 appears below with the corrected values shown in bold.

Reference

1. Kiyotani K, Uno S, Mushiroda T, Takahashi A, Kubo M, Mitsuhata N, et al.. A genome-wide association study identifies four genetic markers for hematological toxicities in cancer patients receiving gemcitabine therapy. Pharmacogenet Genomics 2012; 22:229–235.
Copyright © 2014 Wolters Kluwer Health, Inc. All rights reserved.